Scientific articleRenal cell carcinoma: Survival and prognostic factors
References (30)
- et al.
Aggressive surgical approach to renal cell carcinoma: review of 130 cases
J Urol
(1979) - et al.
The results of radical nephrectomy for renal cell carcinoma
J Urol
(1969) - et al.
The surgical management of renal cell carcinoma
J Urol
(1972) - et al.
Renal tumors: pathology and prognosis in 295 cases
J Urol
(1951) - et al.
The natural history of metastatic renal cell carcinoma: a computer analysis
J Urol
(1978) - et al.
Prognostic significance of renal vein invasion of hypernephroma
J Urol
(1968) - et al.
Renal cell carcinoma: natural history and results of treatment
J Urol
(1978) - et al.
Renal adenocarcinoma in young adults: survival and variables affecting prognosis
J Urol
(1981) - et al.
Renal cell carcinoma: long-term survival and late recurrences
J Urol
(1981) - et al.
Prognostic indicators in renal adenocarcinoma
J Urol
(1983)
The influence of perinephric fat involvement on survival in patients with renal cell carcinoma extending into the inferior vena cava
J Urol
Renal cell carcinoma extending into inferior vena cava
J Urol
Malignant neoplasm of the kidney: an analysis of 353 patients followed five years or more
J Urol
The role of lymphadenectomy in the management of renal cell carcinoma
Urol Clin North Am
Metastatic processes and a potential indication of treatment for metastatic lesions of renal adenocarcinoma
J Urol
Cited by (290)
The natural history of renal cell carcinoma with isolated lymph node metastases following surgical resection from 2006 to 2013
2019, Urologic Oncology: Seminars and Original InvestigationsCitation Excerpt :Although pN1 M0 RCC is associated with a poor prognosis, a subset of patients demonstrates long-term survival, with 10-year overall survival ranging from 5% to 39% [1–4]. Unfortunately, data regarding pN1 M0 RCC have been largely limited to small, institutional or multi-institutional series, and comprised cohorts treated predominantly prior to the introduction of targeted therapy [2–13]. Moreover, there is evidence for substantial heterogeneity in the clinical outcomes of patients with pN1 M0 RCC [2], highlighting a need for predictive tools to facilitate postoperative prognostication and risk-adapted management.
Kidney and Ureteral Carcinoma
2015, Clinical Radiation OncologyThyroid metastasis from clear cell renal carcinoma
2014, Endocrinologia y NutricionSorafenib or sunitinib as postoperative adjuvant therapy for Chinese patients with locally advanced clear cell renal cell carcinoma at high risk for disease recurrence
2013, Urologic Oncology: Seminars and Original InvestigationsCitation Excerpt :A quarter of RCC patients present with locally advanced or metastatic RCC, and RCC is the 10th leading cause of cancer-related death in men [3]. Surgical resection of the affected kidney is the most reliable treatment modality for about 70% of locally advanced RCC [4,5], while 35%–65% of patients experience recurrence postoperatively [6]. Nephrectomy alone may not be sufficient as a strategy in high risk patients with locally advanced RCC.
Association Between Sarcopenia and Survival of Patients with Organ-Confined Renal Cell Carcinoma after Radical Nephrectomy
2022, Annals of Surgical Oncology